Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP535933.RAQiVNXxk9pk16ama7Aj4xYt19Ck9cSz_Ri6Cp5W0XuSk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP535933.RAQiVNXxk9pk16ama7Aj4xYt19Ck9cSz_Ri6Cp5W0XuSk130_assertion type Assertion NP535933.RAQiVNXxk9pk16ama7Aj4xYt19Ck9cSz_Ri6Cp5W0XuSk130_head.
- NP535933.RAQiVNXxk9pk16ama7Aj4xYt19Ck9cSz_Ri6Cp5W0XuSk130_assertion description "[Pre-incubation of SH-SY5Y human neuroblastoma cells with either RAR-pan-antagonist LE540 or MAP kinase kinase 1 (MEK-1) inhibitor PD98059 resulted in the abolition of ATRA-induced COX-2 promoter activity, COX-2 protein expression and PGE2 production whereas the retinoid X receptor pan-antagonist HX531, the p38 MAPK inhibitor SB203580 or the c-Jun kinase inhibitor SP600125 did not have any effect.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535933.RAQiVNXxk9pk16ama7Aj4xYt19Ck9cSz_Ri6Cp5W0XuSk130_provenance.
- NP535933.RAQiVNXxk9pk16ama7Aj4xYt19Ck9cSz_Ri6Cp5W0XuSk130_assertion evidence source_evidence_literature NP535933.RAQiVNXxk9pk16ama7Aj4xYt19Ck9cSz_Ri6Cp5W0XuSk130_provenance.
- NP535933.RAQiVNXxk9pk16ama7Aj4xYt19Ck9cSz_Ri6Cp5W0XuSk130_assertion SIO_000772 17204142 NP535933.RAQiVNXxk9pk16ama7Aj4xYt19Ck9cSz_Ri6Cp5W0XuSk130_provenance.
- NP535933.RAQiVNXxk9pk16ama7Aj4xYt19Ck9cSz_Ri6Cp5W0XuSk130_assertion wasDerivedFrom befree-20140225 NP535933.RAQiVNXxk9pk16ama7Aj4xYt19Ck9cSz_Ri6Cp5W0XuSk130_provenance.
- NP535933.RAQiVNXxk9pk16ama7Aj4xYt19Ck9cSz_Ri6Cp5W0XuSk130_assertion wasGeneratedBy ECO_0000203 NP535933.RAQiVNXxk9pk16ama7Aj4xYt19Ck9cSz_Ri6Cp5W0XuSk130_provenance.